This project is part of the EDCTP2 Programme supported by the European Union.
This project is part of the EDCTP2 Programme supported by the European Union.
Dear Reader, On behalf of the SINDOFO Consortium, we wish you a happy, healthy and successful 2023. 2022 was an eventful year for the project with a lot of achievements
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
The Lancet infectious diseases
Peer reviewed article